BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 6248866)

  • 21. Human urogastrone and mouse epidermal growth factor share a common receptor site in cultured human fibroblasts.
    Hollenberg MD; Gregory H
    Life Sci; 1977 Jan; 20(2):267-74. PubMed ID: 190507
    [No Abstract]   [Full Text] [Related]  

  • 22. Selective reduction in receptors for epidermal growth factor-urogastrone in chemically transformed tumorigenic Syrian hamster embryo fibroblasts.
    Hollenberg MD; Barrett JC; Ts'o PO; Berhanu P
    Cancer Res; 1979 Oct; 39(10):4166-9. PubMed ID: 225016
    [No Abstract]   [Full Text] [Related]  

  • 23. Synergistic actions of epidermal growth factor-urogastrone and vasopressin in cultured aortic A-10 smooth muscle cells.
    Mokashi S; Severson DL; Hollenberg MD
    J Cell Physiol; 1992 Aug; 152(2):372-81. PubMed ID: 1386368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conversion of high molecular weight human epidermal growth factor (hEGF)/urogastrone (UG) to small molecular weight hEGF/UG by mouse EGF-associated arginine esterase.
    Hirata Y; Orth DN
    J Clin Endocrinol Metab; 1979 Sep; 49(3):481-3. PubMed ID: 313937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lectin-agarose immobilization, a new method for detecting soluble membrane receptors. Application to studies with epidermal growth factor-urogastrone and transcobalamin-II.
    Nexł E; Hock RA; Hollenberg MD
    J Biol Chem; 1979 Sep; 254(18):8740-3. PubMed ID: 314449
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased soluble EGF after ischemia is accompanied by a decrease in membrane-associated precursors.
    Schaudies RP; Johnson JP
    Am J Physiol; 1993 Mar; 264(3 Pt 2):F523-31. PubMed ID: 8456964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
    Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS
    Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct coronary artery receptor systems for epidermal growth factor-urogastrone.
    Gan BS; Hollenberg MD
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1277-82. PubMed ID: 2319470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demonstration of significant epidermal growth factor activity in murine thyroid tissue.
    Dagogo-Jack S; Atkinson S; Kendall-Taylor P
    J Endocrinol; 1986 Jul; 110(1):67-72. PubMed ID: 3488365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinctive actions of epidermal growth factor-urogastrone in isolated smooth muscle preparations from guinea pig stomach: differential inhibition by indomethacin.
    Muramatsu I; Itoh H; Lederis K; Hollenberg MD
    J Pharmacol Exp Ther; 1988 May; 245(2):625-31. PubMed ID: 3259262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor-urogastrone causes vasodilatation in the anesthetized dog.
    Gan BS; MacCannell KL; Hollenberg MD
    J Clin Invest; 1987 Jul; 80(1):199-206. PubMed ID: 3496362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcineurin-mediated dephosphorylation of the human placental membrane receptor for epidermal growth factor urogastrone.
    Pallen CJ; Valentine KA; Wang JH; Hollenberg MD
    Biochemistry; 1985 Aug; 24(18):4727-30. PubMed ID: 2416335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of the human placenta receptor for epidermal growth factor-urogastrone.
    Hock RA; Nexø E; Hollenberg MD
    Nature; 1979 Feb; 277(5695):403-5. PubMed ID: 233121
    [No Abstract]   [Full Text] [Related]  

  • 34. [Human epidermal growth factor(urogastrone) in human fluids detected by radioreceptor assay].
    Nakamura K; Imai Y; Matuzaki F
    Nihon Naibunpi Gakkai Zasshi; 1983 Oct; 59(10):1587-96. PubMed ID: 6607183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased binding of epidermal growth factor at preimplantation sites in mouse uteri.
    Brown MJ; Zogg JL; Schultz GS; Hilton FK
    Endocrinology; 1989 Jun; 124(6):2882-8. PubMed ID: 2785911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitation of epidermal growth factor in the rat. Identification and partial characterization of duodenal EGF.
    Olsen PS; Nexø E
    Scand J Gastroenterol; 1983 Sep; 18(6):771-6. PubMed ID: 6608137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid-dependent maturation of neonatal brain but not lung epidermal growth factor receptors.
    Sadiq HF; Chechani V; Devaskar SU; Devaskar UP
    Dev Pharmacol Ther; 1985; 8(5):292-301. PubMed ID: 2994970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal growth factor (EGF)-like transforming growth factor (TGF) activity and EGF receptors in ovine fetal tissues: possible role for TGF in ovine fetal development.
    Freemark M; Comer M
    Pediatr Res; 1987 Nov; 22(5):609-15. PubMed ID: 3500450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoradiographic localization of binding sites for epidermal growth factor-urogastrone (EGF-URO) in coronary arteries.
    Gan BS; Hollenberg MD
    Eur J Pharmacol; 1989 Aug; 167(3):407-10. PubMed ID: 2806378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal growth factor receptor levels in mouse mammary glands in various physiological states.
    Edery M; Pang K; Larson L; Colosi T; Nandi S
    Endocrinology; 1985 Jul; 117(1):405-11. PubMed ID: 2988925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.